000130828 001__ 130828 000130828 005__ 20240228143500.0 000130828 0247_ $$2doi$$a10.1158/0008-5472.CAN-15-2932 000130828 0247_ $$2pmid$$apmid:27197185 000130828 0247_ $$2ISSN$$a0008-5472 000130828 0247_ $$2ISSN$$a0099-7013 000130828 0247_ $$2ISSN$$a0099-7374 000130828 0247_ $$2ISSN$$a1538-7445 000130828 0247_ $$2altmetric$$aaltmetric:6750749 000130828 037__ $$aDKFZ-2017-05906 000130828 041__ $$aeng 000130828 082__ $$a610 000130828 1001_ $$0P:(DE-HGF)0$$aWeber, Claudia E M$$b0$$eFirst author 000130828 245__ $$amiR-339-3p Is a Tumor Suppressor in Melanoma. 000130828 260__ $$aPhiladelphia, Pa.$$bAACR$$c2016 000130828 3367_ $$2DRIVER$$aarticle 000130828 3367_ $$2DataCite$$aOutput Types/Journal article 000130828 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1524555534_9717 000130828 3367_ $$2BibTeX$$aARTICLE 000130828 3367_ $$2ORCID$$aJOURNAL_ARTICLE 000130828 3367_ $$00$$2EndNote$$aJournal Article 000130828 520__ $$aDeterminants of invasion and metastasis in cancer remain of great interest to define. Here, we report the definition of miR-339-3p as a novel tumor suppressive microRNA that blocks melanoma cell invasion without affecting cell survival. miR-339-3p was identified by a comprehensive functional screen of a human miRNA mimetic library in a cell-based assay for invasion by the melanoma cell line A375. miR-339-3p was determined as a strong inhibitor of invasion differentially expressed in melanoma cells and healthy melanocytes. MCL1 was defined as a target for downregulation by miR-339-3p, functioning through direct interaction with the 3' untranslated region of MCL1 mRNA. Blocking miR-339-3p by an antagomiR was sufficient to increase melanoma cell invasion, an effect that could be phenocopied by RNAi-mediated silencing of MCL1. In vivo studies established that miR-339-3p overexpression was sufficient to decrease lung colonization by A375 melanoma cells in NSG mice, relative to control cells. Overall, our results defined miR-339-3p as a melanoma tumor suppressor, the levels of which contributes to invasive aggressiveness. Cancer Res; 76(12); 3562-71. ©2016 AACR. 000130828 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0 000130828 588__ $$aDataset connected to CrossRef, PubMed, 000130828 650_7 $$2NLM Chemicals$$aMIRN-339 microRNA, mouse 000130828 650_7 $$2NLM Chemicals$$aMcl1 protein, mouse 000130828 650_7 $$2NLM Chemicals$$aMicroRNAs 000130828 650_7 $$2NLM Chemicals$$aMyeloid Cell Leukemia Sequence 1 Protein 000130828 7001_ $$0P:(DE-HGF)0$$aLuo, Chonglin$$b1 000130828 7001_ $$0P:(DE-He78)2f34b89d62d5e5c651aa1e683844b092$$aHotz-Wagenblatt, Agnes$$b2$$udkfz 000130828 7001_ $$0P:(DE-He78)cce6b51dcd85173b43b8b662ea47c700$$aGardyan, Adriane$$b3$$udkfz 000130828 7001_ $$0P:(DE-He78)70e630b77e8ddc41353fc23197569b7c$$aKordaß, Theresa$$b4$$udkfz 000130828 7001_ $$0P:(DE-He78)457c042884c901eb0a02c18bb1d30103$$aHolland-Letz, Tim$$b5$$udkfz 000130828 7001_ $$0P:(DE-He78)b757b21d60bbaa4164899bb7e61b0c15$$aOsen, Wolfram$$b6$$udkfz 000130828 7001_ $$0P:(DE-He78)23fb8cfffbf2aa8eee5d51af417ad944$$aEichmüller, Stefan$$b7$$eLast author$$udkfz 000130828 773__ $$0PERI:(DE-600)2036785-5$$a10.1158/0008-5472.CAN-15-2932$$gVol. 76, no. 12, p. 3562 - 3571$$n12$$p3562 - 3571$$tCancer research$$v76$$x1538-7445$$y2016 000130828 909CO $$ooai:inrepo02.dkfz.de:130828$$pVDB 000130828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ 000130828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ 000130828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2f34b89d62d5e5c651aa1e683844b092$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ 000130828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)cce6b51dcd85173b43b8b662ea47c700$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ 000130828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)70e630b77e8ddc41353fc23197569b7c$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ 000130828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)457c042884c901eb0a02c18bb1d30103$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ 000130828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b757b21d60bbaa4164899bb7e61b0c15$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ 000130828 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)23fb8cfffbf2aa8eee5d51af417ad944$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ 000130828 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0 000130828 9141_ $$y2016 000130828 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline 000130828 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER RES : 2015 000130828 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS 000130828 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database 000130828 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search 000130828 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC 000130828 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List 000130828 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index 000130828 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection 000130828 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded 000130828 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine 000130828 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences 000130828 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews 000130828 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER RES : 2015 000130828 9201_ $$0I:(DE-He78)G182-20160331$$kG182$$lGMP Einheit Zelluläre Therapie$$x0 000130828 9201_ $$0I:(DE-He78)W180-20160331$$kW180$$lBioinformatik (HUSAR)$$x1 000130828 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x2 000130828 980__ $$ajournal 000130828 980__ $$aVDB 000130828 980__ $$aI:(DE-He78)G182-20160331 000130828 980__ $$aI:(DE-He78)W180-20160331 000130828 980__ $$aI:(DE-He78)C060-20160331 000130828 980__ $$aUNRESTRICTED